General Partner Inc’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29K Hold
75
0.02% 139
2026
Q1
$22K Hold
75
0.01% 138
2025
Q4
$26.3K Hold
75
0.01% 140
2025
Q3
$24.2K Hold
75
0.01% 143
2025
Q2
$29.2K Hold
75
0.02% 139
2025
Q1
$32.6K Hold
75
0.02% 131
2024
Q4
$27.7K Hold
75
0.02% 137
2024
Q3
$39K Hold
75
0.02% 127
2024
Q2
$40.6K Hold
75
0.03% 127
2024
Q1
$38.9K Hold
75
0.02% 131
2023
Q4
$35.4K Hold
75
0.03% 96
2023
Q3
$32.7K Hold
75
0.03% 101
2023
Q2
$33.3K Hold
75
0.03% 101
2023
Q1
$36.3K Sell
75
-106
-59% -$50.4K 0.03% 101
2022
Q4
$92.8K Buy
+181
New +$91.9K 0.09% 83

Other funds holding ELV

General Partner Inc's ELV Position: Q2 2026 in Review

General Partner Inc held its Elevance Health (ELV) position steady in Q2 2026 at 75 shares worth $29K. The position accounts for 0.02% of the portfolio, ranked #139.

General Partner Inc first reported a position in ELV in Q4 2022 and has held it in 15 quarters since. The position peaked at $92.8K in Q4 2022. 222 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • General Partner Inc held 75 shares of Elevance Health worth $29K as of Q2 2026.
  • General Partner Inc left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up 0.02% of General Partner Inc's portfolio in Q2 2026, its #139 holding.
  • General Partner Inc first reported a position in Elevance Health in Q4 2022 and has held it in 15 quarters since.
  • General Partner Inc's Elevance Health position peaked at $92.8K in Q4 2022.
  • 222 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on General Partner Inc's 13F filing for Q2 2026, filed 6 Jul 2026.